Hospitals | October 18, 2021
GPT Healthcare to go public to fund expansion
The company operates four mid-sized hospitals with a total bed capacity of 556 in eastern India
The company operates four mid-sized hospitals with a total bed capacity of 556 in eastern India
Equity raise to finance growth and investments in the biological space
Emkay Research expects Q2FY22 to be a normalised quarter for pharma companies that it tracks. A summary of the report
The company’s pharmaceutical API products Ibuprofen and fenofibrate got the go-ahead
It is one of the first companies to launch a bioequivalent version of the dry powder inhaler and it's part of the company’s strategic exclusive in-licensing arrangement to market Tiotropium DPI in Western Europe and the UK
The company plans to expand its portfolio in regulated markets aggressively
Next-generation radiofrequency catheter offers first thermal ablation perforator treatment advancement in over 10 years
_256_384.jpg)
In Q2FY22, growth from Covid-driven products in the domestic branded formulation sales should dissipate on a QoQ basis as new covid cases have declined sharply. Vishal Manchanda, research analyst Nirmal Bang gives a preview of pharma companies in this report
Ectosense’s NightOwl is a leading cloud-connected home sleep apnea test
Its store network grew from 144 stores in March 2019 to 236 stores. It has a presence in 23 cities across Maharashtra, Goa and Karnataka, employing more than 4,600 people.
Subscribe To Our Newsletter & Stay Updated
